Article
Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profiling.
Neurobiology of disease - 1 Jul 2021
Pallos Judit, Jeng Sophia, McWeeney Shannon, Martin Ian
Abstract excerpt
Leucine-rich repeat kinase 2 (LRRK2) mutations are the most common genetic cause of late-onset Parkinson's disease. The pathogenic G2019S mutation enhances LRRK2 kinase activity and induces neurodegeneration in C. elegans, Drosophila and rodent models through unclear mechanisms. Gene expression profiling has the potential to provide detailed insight into the biological pathways modulated by LRRK2 kinase activity....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
